Cost-effectiveness of CT screening in the national lung screening trial

Keyphrases

• Cost-effectiveness 100%
• Confidence Interval 100%
• National Lung Screening Trial 100%
• Computed Tomography Screening 100%
• Low-dose Computed Tomography 80%
• Quality-adjusted Life Years 80%
• Life-years Gained 60%
• Incremental Cost-effectiveness Ratio 60%
• Lung Cancer Risk 40%
• Sensitivity Analysis 40%
• Subgroup Analysis 20%
• Medicare Reimbursement 20%
• Radiography 20%
• Utilization Rate 20%
• Smoking History 20%
• Smoking Risk 20%
• Quality of Life Survey 20%
• Chest Radiography 20%
• Low-dose Computed Tomography Screening 20%
• Mean Life 20%
• Quality Adjustment 20%
• Screening for Lung Cancer 20%

Medicine and Dentistry

• Cost-Effectiveness Analysis 100%
• Computer Assisted Tomography 100%
• National Lung Screening Trial 100%
• Health Care Cost 83%
• Low Drug Dose 83%
• Quality Adjusted Life Year 66%
• Lung Cancer 50%
• Quality of Life 16%
• Medicare 16%
• Subgroup Analysis 16%
• Cancer Mortality 16%
• Thorax Radiography 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Cancer 100%
• Cancer Mortality 33%